ICNDDT · Registering as Listener

International Conference on Neurodegenerative Diseases and Therapeutics

📅 5–6 Jun 2027 📍 Tunis, Tunisia 👤 Standard / Listener

Listener registration from

$165

virtual · $165 in person

Registration benefits
✉
Official invitation letterIssued automatically after registration
📜
Certificate & digital materialsCertificate, slides and resource materials
🌐
Supporting global researchConnect with researchers across 30+ countries

For Support Please Contact

[email protected]

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessionsNetworkingCertificateInvitation letterConference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon code

Have a code? Apply it here — the discount updates the total immediately.

Apply

I agree to the Terms & Conditions and Refund & Cancellation Policy.

VISAMastercardAmexPayPal

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Conference session tracks

Key research areas covered across the sessions — tap a track to read more.

This session will explore the underlying biological mechanisms that contribute to neurodegenerative diseases. Emphasis will be placed on recent discoveries in cellular and molecular pathways involved in conditions such as Alzheimer's and Parkinson's.

This track will focus on novel therapeutic strategies for managing neurodegenerative diseases. Presentations will cover cutting-edge research in drug development, gene therapy, and personalized medicine.

This session will examine the role of neuroinflammation in the progression of neurodegenerative diseases. Discussions will highlight the interplay between immune responses and neuronal health.

This track will delve into the cognitive deficits associated with various neurodegenerative diseases. Research findings on assessment tools and interventions aimed at improving cognitive function will be presented.

This session will focus on the identification and validation of biomarkers for early detection of neurodegenerative diseases. The importance of biomarkers in clinical trials and patient management will also be discussed.

This track will explore strategies aimed at protecting neuronal cells from degeneration. Topics will include pharmacological agents, lifestyle interventions, and their implications for patient care.

This session will emphasize the importance of patient-centered care in the management of neurodegenerative diseases. Discussions will include the integration of patient preferences and experiences into therapeutic decision-making.

This track will highlight the latest advancements in neuroimaging technologies for studying neurodegenerative diseases. Presentations will focus on how these techniques enhance our understanding of disease progression and treatment efficacy.

This session will investigate the genetic and environmental factors contributing to the risk of developing neurodegenerative diseases. The interplay between genetic predisposition and lifestyle choices will be a key focus.

This track will address the ethical challenges associated with research in neurodegenerative diseases. Discussions will include informed consent, patient autonomy, and the implications of emerging therapies.

This session will explore future research directions and emerging trends in the field of neurodegenerative diseases. Participants will discuss potential breakthroughs and the impact of interdisciplinary approaches on therapeutic development.